Sort
8,912 grants matching “sars cov 2”
Consequences of Persistent Immune Activation among ART-treated Women with HIV
$181,575Markella V. Zanni · Massachusetts General Hospital · K24 · FY2022 · AI
Consequences of Persistent Immune Activation among ART-treated Women with HIV
$181,575Markella V. Zanni · Massachusetts General Hospital · K24 · FY2024 · AI
Molecular Biology of Viral Diseases
$181,561Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · T32 · FY2010 · AI
Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
$181,439Ankur Singh · Georgia Institute Of Technology · R21 · FY2021 · AI
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
$181,250Diane Bimczok · Montana State University - Bozeman · R21 · FY2024 · AI
Innate immune pathways underlying sexual dimorphism in obesity pathogenesis
$181,144Meera Goh Nair · University Of California Riverside · R21 · FY2025 · AI
Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk
$180,957Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Determining SARS-CoV host gene requirements by mutagenesis and RNA interface
$180,872Robert J Hogan · University Of Georgia · R21 · FY2008 · AI
Automating the Discovery of Clinically-Relevant Intracellular Signaling Responses in Immune Cell-Types
$180,866Natalie M Stanley · Univ Of North Carolina Chapel Hill · R21 · FY2023 · AI
Core C: Immunoglobulin Proteomics in COVID-19
$180,753Gregory C Ippolito · Univ Of North Carolina Chapel Hill · U54 · FY2022 · CA
A Novel Paradigm for the Development of a Peptide Vaccine to Treat KRAS Mutant Cancers
$180,637Albert J. Wong · Stanford University · R21 · FY2022 · CA
Determining the role of AnnexinA2 in HIV-1 and SARS-CoV-2 assembly
$180,599Peter William Ramirez · California State University Long Beach · R16 · FY2024 · AI
In Silico Screening for Cancer Targets
$180,592Marc Nicklaus · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Informatics Approach to Identification and Deep Phenotyping of PASC Cases
$180,446Xiaoming Li · University Of South Carolina At Columbia · R21 · FY2023 · AI
RAPID: The Role of Testing in COVID-19 Outbreak Control
$180,401Lauren M Childs · Virginia Polytechnic Institute And State University · · FY2020 · MPS
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
$180,129Amber Reeves-Daniel · Wake Forest University Health Sciences · U01 · FY2023 · DK
COVID-19 Related Work: Molecular Parasitology Section/LPD
$179,976Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Prevalence of Coronaviruses in Wild Rodents
$179,709William A Schountz · Colorado State University · R21 · FY2025 · AI
Cytoscape: A Modeling Platform for Biomolecular Networks
$179,529Trey Ideker · University Of California, San Diego · R01 · FY2020 · HG
Investigator Development
$179,522Brian Richard McNaughton · Delaware State University · U54 · FY2022 · MD
Neuroendocrine control of TLR4-dependent inflammation in influenza
$179,500Kari Ann Shirey · University Of Maryland Baltimore · R21 · FY2022 · AI
MIcrophysiological systems to model vascular malformations
$179,153Christopher C. W. Hughes · University Of California-Irvine · UH3 · FY2020 · HL
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART
$179,083Shahin Lockman · Brigham And Women'S Hospital · K24 · FY2025 · AI
Technologies and Resources for Core Laboratories
$179,050Laura F Gibson · West Virginia University · U54 · FY2024 · GM
Technologies and Resources for Core Laboratories
$179,050Laura F Gibson · West Virginia University · U54 · FY2023 · GM